-
OncoGenex Pharmaceuticals Inc. (NASDAQ:OGXI) said late Thursday it is planning a follow-on underwritten by Leerink; Stifel Nicolaus Weisel; Lazard; and William Blair. Further details were not disclosed. OncoGenex was up…
Published on 3/15/2012
-
Enterprise Ireland and the National Pensions Reserve Fund committed a total of $37.5 million to Sofinnova Ventures, which will establish a presence in Ireland. The commitment was made via the Innovation Fund Ireland …
Published on 3/15/2012
-
The Welsh Government has committed L50 million ($78.4 million) for its Welsh Life Sciences Fund. The government is seeking contributions from investors to give the fund a total of L100 million ($156.8 million). Chris …
Published on 3/15/2012
-
Kala Pharmaceuticals Inc. (Waltham, Ma.) raised an additional $6.2 million in seed financing, bringing the total raised to $11.2 million. New investor Lighthouse Capital Partners joined existing investors Lux Capital; …
Published on 3/14/2012
-
Medivation Inc. (NASDAQ:MDVN) raised $225 million in a bumped-up offering of 2.625% senior convertible notes due April 1, 2017. The notes initially convert at $102.47 per share, which is a 40% premium to Medivation's …
Published on 3/14/2012
-
Salix Pharmaceuticals Ltd. (NASDAQ:SLXP) raised $600 million in a bumped-up offering of 1.5% senior convertible notes due March 15, 2019. The notes initially convert at $65.81 per share, which is a 35% premium to Salix'…
Published on 3/13/2012
-
Anthera Pharmaceuticals Inc. (NASDAQ:ANTH) fell $2.86 (45%) to $3.56 on Monday after announcing late Friday that it will discontinue development of cardiovascular compound varespladib for all indications. The secretory …
Published on 3/12/2012
-
HemaQuest Pharmaceuticals Inc. (San Diego, Calif.) raised $13 million in an extension of a series B round, bringing the total raised in the round to $29 million. Existing investors Aberdare Ventures; De Novo Ventures; …
Published on 3/12/2012
-
Medivation Inc. (NASDAQ:MDVN) proposed to sell $175 million in unsecured convertible senior notes due April 1, 2017. Citigroup is the sole book-running manager. Details were not disclosed. Medivation, which made the …
Published on 3/12/2012
-
Piper Jaffray is raising $100 million for its new private equity fund, Piper Jaffray Merchant Banking Fund I L.P., according to an SEC filing on March 7. The investment bank and asset management firm could not be …
Published on 3/12/2012
-
Salix Pharmaceuticals Ltd. (NASDAQ:SLXP) proposed to sell $500 million of senior convertible notes due 2019. The notes will be convertible into cash, shares or a combination of both at Salix's election. The company …
Published on 3/12/2012
-
Aastrom Biosciences Inc. (NASDAQ:ASTM) raised $40 million through the sale of 12,300 shares of series B convertible preferred stock at $3,250 in a private placement to Eastern Capital. Each series B preferred stock …
Published on 3/9/2012
-
Kolltan Pharmaceuticals Inc. (New Haven, Conn.) raised $25 million in a series C round. Details were not disclosed. The company is developing mAbs and small molecules that target tyrosine kinase receptors to treat …
Published on 3/9/2012
-
Amylin Pharmaceuticals Inc. (NASDAQ:AMLN) raised $203.1 million through the sale of 13 million shares at $15.62 in a follow-on underwritten by Credit Suisse. The company proposed the offering late Wednesday, when its …
Published on 3/8/2012
-
Bellicum Pharmaceuticals Inc. (Houston, Texas) raised $10 million in the first tranche of a planned $20 million series B round. Undisclosed existing investors participated along with new investors, including AVG …
Published on 3/8/2012
-
Elan Corp. plc (NYSE:ELN) divested a 16% stake, or about $346.5 million, in Alkermes plc (NASDAQ:ALKS). Elan sold 21 million Alkermes shares at $16.50 in a registered offering underwritten by Citigroup; Jefferies; …
Published on 3/8/2012
-
Sosei Co. Ltd. plans to raise Y300 million ($3.7 million) through the sale of 300 preferred shares at Y1 million in a private placement to JAFCO. Additionally, Sosei has until March 31, 2014 to request an additional …
Published on 3/8/2012
-
Amylin Pharmaceuticals Inc. (NASDAQ:AMLN) proposed late Wednesday to sell 13 million shares in a follow-on underwritten by Credit Suisse. If sold at Amylin's close of $16.17 on Wednesday, the company would raise $210.2 …
Published on 3/7/2012
-
Discovery Laboratories Inc. (NASDAQ:DSCO) gained as much as 44% on Wednesday before closing up 9%, or $0.33, to $4.08 after FDA approved Surfaxin lucinactant late Tuesday to prevent respiratory distress syndrome in …
Published on 3/7/2012
-
Genomics company OpGen Inc. (Gaithersburg, Md.) announced a planned series C round of up to $17 million from new and existing investors. Harris & Harris Group and Cross Creek Capital are new investors. Highland Capital …
Published on 3/7/2012
-
Phosphate Therapeutics Ltd. (Newcastle, U.K.) raised EUR 10.5 million ($13.9 million) from Inventages Venture Capital and received exclusive, worldwide rights to phosphate binder PT20 from U.K.'s Medical Research …
Published on 3/7/2012
-
Promedior Inc. (Malvern, Pa.) raised $21.5 million in the first close of a series D round led by new investor Fibrotec Ventures. All of Promedior's existing investors participated, including Morgenthaler Ventures; …
Published on 3/7/2012
-
Provista Diagnostics Inc. (Phoenix, Ariz.) raised $5 million in a series A round from a group of 18 institutional and individual investors, including the Louis-Dreyfus Family Office; Groton Partners; and MacOne. …
Published on 3/7/2012
-
Aragon Pharmaceuticals Inc. (San Diego, Calif.) raised $42 million in a series C round led by new investor Topspin Fund. Existing investors Aisling Capital; OrbiMed; and The Column Group participated. Topspin's Leo …
Published on 3/6/2012
-
Oncothyreon Inc. (NASDAQ:ONTY) fell $3.34 (40%) to $5.07 on Tuesday on news that data from the Phase III START trial of Stimuvax in non-small cell lung cancer will not be available until early 2013, instead of 2H12 as …
Published on 3/6/2012